Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
18 April 2017 |
Main ID: |
ChiCTR-OPN-16010028 |
Date of registration:
|
2016-11-23 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Effects of Tripterygium wilfordii induction therapy to IgA nephropathy patients with heavy proteinuria
|
Scientific title:
|
Effects of Tripterygium wilfordii induction therapy to IgA nephropathy patients with heavy proteinuria |
Date of first enrolment:
|
2011-01-01 |
Target sample size:
|
Prednisone (PRE) group:10;conventional-dose TW (CTW) group:10;double-dose TW (DTW) group:10; |
Recruitment status: |
Completed |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=16968 |
Study type:
|
Observational study |
Study design:
|
Non randomized control
|
Phase:
|
Post-market
|
|
Contacts
|
Name:
|
Li-na Zhou
|
Address:
|
301 Middle Yanchang Road, Shanghai
|
Telephone:
|
+86 15901989527 |
Email:
|
wang.zhen@tongji.edu.cn |
Affiliation:
|
Shanghai Tenth People's Hospital, Tongji University School of Medicine |
|
Name:
|
Zhen Wang
|
Address:
|
301 Middle Yanchang Road, Shanghai
|
Telephone:
|
+86 15901989527 |
Email:
|
wang.zhen@tongji.edu.cn |
Affiliation:
|
Shanghai Tenth People's Hospital, Tongji University School of Medicine |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: IgAN and heavy proteinuria (=3.5 g/24 h)
Exclusion criteria: Patients with other causes of IgA-positive glomerular staining, such as Henoch-Schnlein nephritis and lupus nephritis, were excluded.
The coincidence of IgAN and minimal change disease confirmed by electron microscopy was also excluded from the study.
Age minimum:
21
Age maximum:
54
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
IgA nephropathy
|
Intervention(s)
|
Prednisone (PRE) group:1mg/kg prednisone once daily;conventional-dose TW (CTW) group:60 mg TW daily;double-dose TW (DTW) group:?????120mg;
|
Primary Outcome(s)
|
proteinuria;
|
Source(s) of Monetary Support
|
the Natural Science Foundation of China
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|